Expiry dates on two batches of Atorvastatin 4mg/ml Oral Suspension and Sildenafil 10mg/ml Oral Suspension are incorrect, the Medicines and Healthcare Products Regulatory Agency (MHRA) has advised.

The expiry dates stamped on the base of the bottles of both the statin Atorvastatin - indicated for hypercholesterolaemia and prevention of cardiovascular disease - and Sildenafil - for pulmonary arterial hypertension - are incorrect, according to manufacturer Rosemont Pharmaceuticals.

However, it added that the correct expiry dates are printed on the bottle label and outer carton, and all other product details, including serial numbers and batch details, are correct.

The MHRA has said that the issue poses no risk to product quality, and the batches are not being recalled.

However, healthcare professionals should advise patients of the issue when dispensing the products. Patients should be told to ignore the date printed on the base of the bottle, and instead use the product until the date listed on the bottle label and outer carton.

The MHRA has advised concerned patients to contact their pharmacist.

The affected Atorvastatin 4mg/ml Oral Suspension batches are numbered ATV21001 and ATV21002, and the affected Sildenafil 10mg/ml Oral Suspension batches are numbered SLD22001 and SLD22002.

No other batches of Atorvastatin 4mg/ml Oral Suspension or Sildenafil 10mg/ml Oral Suspension marketed by Rosemont Pharmaceuticals are affected by this discrepancy.